Small interfering RNA targeting LASS2 gene enhances invasion capacity of hepatocellular carcinoma cells

TANG Ning,HaiYan You,JIN Jie,Bin Yu,Wenxin Qin

DOI: https://doi.org/10.3781/j.issn.1000-7431.2009.05.001

2009-01-01

Tumor

Abstract:Objective:To explore the effect of small interference RNA(siRNA) targeting homosapiens longevity assurance homologue 2(LASS2) on invasion for human hepatocellular carcinoma cell line(MHCC97-L).Methods:MHCC97-L cells were transfected with siRNA mediated by lipofectamine 2000.The expression of LASS2 was detected after transfection by real-time fluorogentic quantitative PCR(RFQ-PCR) to screen the effective siRNA fragment.The trans-membrane transport of proton by MHCC97-L cells was determined by measuring extracellular pH(pHe) with pH-sensitive fluorescence probe BCECF.The level of MMP-2 protein in the supernatant was analyzed by Western blotting.The activity of MMP-2 was examined by zymography.Furthermore,the in vitro invasion capacity of MHCC97-L cells was tested using Transwell invasion assay.Results:Two effective siRNA fragments targeting LASS2,siRNA-1 and siRNA-2,were selected.After expression of LASS2 gene was suppressed by siRNA-1 in the MHCC97-L cells,the proton trans-membrane secretion was increased.The difference was significant compared with empty control group(P<0.05).There were no diffe-rences in the expression and synthesis of MMP-2 protein between siRNA-treated group and control groups.However activity of secreted MMP-2 was up-regulated and the in vitro invasion capacity was remarkably enhanced in siRNA-1 treated cells compared with the null sequence group and the empty control group(P<0.05).Conclusion:siRNA targeting LASS2 gene could enhance the cell invasion in vitro by facilitating proton secretion and up-regulating the activation of MMP-2 in MHCC97-L cells.